Process Measures
| Pre-Intervention | Post-Intervention | P Value | |
|---|---|---|---|
| Asthma severity assessed | |||
| Spirometry performed, N, (% of patients) | 32 (1.2%) | 272 (10.1%) | .0031,2 |
| ACT assessed, N, (% of patients) | 0 (0.0%) | 310 (11.5%) | N/A |
| HEDIS measures | |||
| Patients meeting inclusion criteria for HEDIS definition of persistent asthma (% of study sample) | 129 (4.8%) | 228 (8.5%) | <.00011 |
| Asthma medication ratio: percentage identified as having persistent asthma who had a ratio of controller medications to total asthma medications of 0.50 or greater | 52.3% | 58.5% | .3 |
| Medication management for people with asthma: percentage identified as having persistent asthma who were dispensed an asthma controller medication that they remained on for at least: | |||
| 75% of their treatment period | 27.6% | 34.2% | .2 |
| 50% of their treatment period | 56.9% | 63.2% | .3 |
All P values in this table obtained using generalized linear mixed models with random effects to control for variability between clinics. Random effects for subject were included when 1) applicable, and 2) random treatment effects by clinic were included when significant.
ACT, Asthma Control Test; HEDIS, Health care Effectiveness Data and Information Set.